{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:32:26Z","timestamp":1791063146678,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004156.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000}}],"reference-count":34,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004156.pub4","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T19:47:50Z","timestamp":1328903270000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Treatment for spasticity in amyotrophic lateral sclerosis\/motor neuron disease"],"prefix":"10.1002","volume":"2012","author":[{"given":"Nigel L","family":"Ashworth","sequence":"first","affiliation":[{"name":"University of Alberta; Physical Medicine & Rehabilitation; Glenrose Rehabilitation Hospital 10230-111 Avenue Edmonton Alberta Canada T5G 0B7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L E","family":"Satkunam","sequence":"additional","affiliation":[{"name":"University of Alberta; Physical Medicine & Rehabilitation; Glenrose Rehabilitation Hospital 10230-111 Avenue Edmonton Alberta Canada T5G 0B7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Deforge","sequence":"additional","affiliation":[{"name":"University of Ottawa; Division of Physical Medicine and Rehabilitation; The Rehabilitation Center Ottawa Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,2,15]]},"reference":[{"issue":"1-2","key":"10.1002\/14651858.CD004156.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-510X(01)00610-4","article-title":"The value of muscle exercise in patients with amyotrophic lateral sclerosis","volume":"191","author":"Drory","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"10.1002\/14651858.CD004156.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis","volume":"330","author":"Bensimon","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD004156.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF02339903","article-title":"Protirilen tartrate (TRH-T) in upper motoneuron syndrome: a controlled neurophysiological and clinical study","volume":"15","author":"Civardi","year":"1994","journal-title":"Italian Journal of Neurological Sciences"},{"issue":"10","key":"10.1002\/14651858.CD004156.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/jnnp.50.10.1359","article-title":"Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease","volume":"50","author":"Guiloff","year":"1987","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD004156.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archneur.1979.00500470085019","article-title":"Trial of Baclofen in amyotrophic lateral sclerosis","volume":"36","author":"Norris FH Jr","year":"1979","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004156.pub4-BIB0006|cit6","first-page":"540","article-title":"Preliminary trial of carisprodol in multiple sclerosis","volume":"192","author":"Ashworth","year":"1964","journal-title":"Practitioner"},{"issue":"1","key":"10.1002\/14651858.CD004156.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0141-5425(84)90003-7","article-title":"Pendulum testing of spasticity","volume":"6","author":"Bajd","year":"1984","journal-title":"Journal of Biomedical Engineering"},{"issue":"8","key":"10.1002\/14651858.CD004156.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00005650-198108000-00001","article-title":"The Sickness Impact Profile: development and final revision of a health status measure","volume":"19","author":"Bergner","year":"1981","journal-title":"Medical Care"},{"issue":"2","key":"10.1002\/14651858.CD004156.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Physical Therapy"},{"issue":"Suppl","key":"10.1002\/14651858.CD004156.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Research Group on Neuromuscular Diseases and the El Escorial \"Clinical Limits of amyotrophic lateral sclerosis\" workshop contributors","volume":"124","author":"Brooks","year":"1994","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD004156.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004156.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1047-9651(18)30290-0","article-title":"Comprehensive management of amyotrophic lateral sclerosis","volume":"9","author":"Carter","year":"1998","journal-title":"Physical Medicine and Rehabilitation Clinics of North America"},{"issue":"12","key":"10.1002\/14651858.CD004156.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/jnnp.55.12.1106","article-title":"Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950","volume":"55","author":"Chancellor","year":"1992","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD004156.pub4-BIB0014|cit14","volume-title":"The handbook of research synthesis","author":"Cooper","year":"1994"},{"issue":"2","key":"10.1002\/14651858.CD004156.pub4-BIB0015|cit15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005229.pub2","article-title":"Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease","author":"Dal Bello-Haas","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004156.pub4-BIB0016|cit16","first-page":"47","article-title":"Gabapentin for the treatment of spasticity in patients with ALS","volume":"2","author":"Carvalho","year":"2001","journal-title":"Amyotrophic lateral sclerosis & other motor neuron disorders"},{"issue":"2","key":"10.1002\/14651858.CD004156.pub4-BIB0017|cit17","first-page":"67","article-title":"Featured instrument. The Functional Independence Measure (FIM instrument)","volume":"1","author":"Deutsch","year":"1997","journal-title":"Journal of Rehabilitation Outcomes Measurement"},{"key":"10.1002\/14651858.CD004156.pub4-BIB0018|cit18","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD004156.pub4-BIB0019|cit19","first-page":"1","article-title":"The motor neuron diseases and related disorders","volume-title":"Clinical Neurology","volume":"4","author":"Hudson","year":"1991"},{"issue":"4","key":"10.1002\/14651858.CD004156.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0003-9993(92)90007-J","article-title":"Objective quantification of spastic hypertonia: correlation with clinical findings","volume":"73","author":"Katz","year":"1992","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"5","key":"10.1002\/14651858.CD004156.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0003-9993(21)01620-8","article-title":"The effect of a high resistance exercise program in slowly progressive neuromuscular disease","volume":"75","author":"Kilmer","year":"1994","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"7","key":"10.1002\/14651858.CD004156.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s004150050417","article-title":"Intrathecal baclofen for intractable spasticity in ALS","volume":"256","author":"Marquardt","year":"1999","journal-title":"Journal of Neurology"},{"issue":"Suppl","key":"10.1002\/14651858.CD004156.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/(SICI)1097-4598(1997)6+<1::AID-MUS2>3.0.CO;2-D","article-title":"Clinicophysiological concepts of spasticity and motor dysfunction in adults with an upper motorneuron lesion","volume":"6","author":"Mayer","year":"1997","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD004156.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00002060-199905000-00012","article-title":"Continuously infused intrathecal baclofen for spastic\/dystonic hemiplegia","volume":"78","author":"Meythaler","year":"1999","journal-title":"American Journal of Physical Medicine and Rehabilitation"},{"issue":"5","key":"10.1002\/14651858.CD004156.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0404.1992.tb04048.x","article-title":"Mechanisms of baclofen action on spasticity","volume":"85","author":"Milanov","year":"1992","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD004156.pub4-BIB0026|cit26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001447.pub2","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neurone disease (MND)","author":"Miller","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004156.pub4-BIB0027|cit27","first-page":"p41","volume-title":"The diagnosis and treatment of Amyotrophic Lateral Sclerosis","author":"Mulder DW","year":"1980"},{"issue":"4","key":"10.1002\/14651858.CD004156.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1212\/WNL.36.4.511","article-title":"Familial adult motor neuron disease: amyotrophic lateral sclerosis","volume":"36","author":"Mulder","year":"1986","journal-title":"Neurology"},{"issue":"11Suppl 9","key":"10.1002\/14651858.CD004156.pub4-BIB0029|cit29","first-page":"S44","article-title":"Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group","volume":"44","author":"Nance","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004156.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0022-510X(93)90245-T","article-title":"Onset, natural history and outcome in idiopathic adult motor neuron disease","volume":"118","author":"Norris","year":"1993","journal-title":"Journal of the Neurological Sciences"},{"issue":"23","key":"10.1002\/14651858.CD004156.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","article-title":"Intrathecal baclofen for severe spinal spasticity","volume":"320","author":"Penn","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"3-4","key":"10.1002\/14651858.CD004156.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0361-9230(93)90269-H","article-title":"Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartate-glutamate in amyotrophic lateral sclerosis","volume":"30","author":"Plaitaikis","year":"1993","journal-title":"Brain Research Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD004156.pub4-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001332","article-title":"Anti-spasticity agents for multiple sclerosis","author":"Shakespeare","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004156.pub4-BIB0034|cit34","first-page":"237","article-title":"Baclofen effect on quadriceps strength in multiple sclerosis","volume":"73","author":"Smith","year":"1992","journal-title":"Archives of Physical Medicine & Rehabilitation"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004156.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:17:18Z","timestamp":1747034238000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004156.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,15]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004156.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,15]]}}}